Indo-MIM Limited Confirms Proper Utilization of Rs. 500 Crore IPO Proceeds in Q2 2026
CARE Ratings Limited Monitoring Report for quarter ended September 30, 2026, shows no deviation from IPO fund utilization plans
Indo-MIM Limited has disclosed the Monitoring Agency Report for the quarter ended September 30, 2026, confirming that the Rs. 500 crore raised through its Initial Public Offer has been utilized as per the offer document with no deviations. The report by CARE Ratings Limited assures no material changes or approvals pending related to the IPO proceeds utilization.
Indo-MIM Limited
Legal / Regulatory
Indo-MIM Limited has reported through a Monitoring Agency Report that the Rs. 500 crore raised from its Initial Public Offer has been utilized in accordance with the offer document for the quarter ended September 30, 2026.
The Monitoring Agency, CARE Ratings Limited, issued the report on November 13, 2026, confirming no material deviations in the utilization of IPO proceeds by Indo-MIM Limited.
The IPO was conducted from July 23, 2026, to July 27, 2026, raising Rs. 500 crore through equity shares as a public issue.
The proceeds are earmarked primarily for repayment or prepayment of outstanding borrowings (Rs. 400 crore), general corporate purposes (Rs. 85.437 crore), and issue expenses (Rs. 14.563 crore) as per the Red Herring Prospectus.
CARE Ratings noted that some company funds were routed through current accounts containing multiple transactions, leading to commingling of funds; nonetheless, the agency relied on alternative bank statements, RTGS receipts and email confirmations to verify fund utilization.
The report confirms that all utilization aligns with disclosures, with no shareholder approvals required for deviations since none occurred during the quarter under review.
Highlights
- No deviation observed from the objects disclosed in the IPO offer document.
- Rs. 500 crore raised through IPO comprises Rs. 400 crore for debt repayment, Rs. 85.437 crore for general corporate purposes, and Rs. 14.563 crore for issue expenses.
- Monitoring Agency CARE Ratings Limited submitted the report on November 13, 2026, covering activity until September 30, 2026.
- The company’s fund transactions involved commingled current accounts; CARE Ratings confirmed fund utilization through alternative verifications.
- No government or statutory approvals are pending related to the IPO proceeds utilization.
Key Data Snapshot
What happened
- Indo-MIM Limited raised Rs. 500 crore through an Initial Public Offer conducted from July 23 to July 27, 2026.
- CARE Ratings Limited, acting as the Monitoring Agency, issued a report confirming the IPO proceeds were utilized as per the offer document for the quarter ended September 30, 2026.
- No material deviation or change to the utilization plan was detected during the reporting period.
- The report was submitted on November 13, 2026, and is available on the company’s website.
Key details
- The IPO proceeds are allocated for repayment/prepayment of borrowings (Rs. 400 crore), general corporate purposes (Rs. 85.437 crore), and issue expenses (Rs. 14.563 crore).
- The proceeds were routed through current accounts containing other transactions, confirmed by alternative documentation.
- No shareholder approvals were necessary as there were no deviations from projected expenditures.
- There are no pending government or statutory approvals related to the IPO objectives.
Regulatory and governance context
- The report complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
- CARE Ratings Limited stated no conflict of interest in performing the monitoring role.
- The Monitoring Agency does not independently audit but relies on issuer-provided data and certifications.
Highlights
- No deviation observed from the objects disclosed in the IPO offer document.
- Rs. 500 crore raised through IPO comprises Rs. 400 crore for debt repayment, Rs. 85.437 crore for general corporate purposes, and Rs. 14.563 crore for issue expenses.
- Monitoring Agency CARE Ratings Limited submitted the report on November 13, 2026, covering activity until September 30, 2026.
- The company’s fund transactions involved commingled current accounts; CARE Ratings confirmed fund utilization through alternative verifications.
- No government or statutory approvals are pending related to the IPO proceeds utilization.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
More News on Legal / Regulatory
View allLatest corporate announcements and market updates in Legal / Regulatory.
Tata Chemicals denies Tata Sons IPO talks amid share rally, confirms no undisclosed information
Tata Chemicals Limited has officially denied any involvement or knowledge of negotiations concerning a Tata Sons IPO, addressing market speculation that led to an up to 9% rally in related shares. The company confirmed it has no undisclosed information or ongoing regulatory or legal proceedings.
Read Full StoryAirfloa Rail Technology Limited Reports Zero Utilisation of IPO Proceeds in Q2 2026 per CRISIL Monitoring Report
Airfloa Rail Technology Limited submitted its Monitoring Agency Report from CRISIL for the quarter ended September 30, 2026, confirming no utilisation of the net IPO funds amounting to Rs. 8,884.80 lakhs during the period with adherence to SEBI regulatory requirements.
Read Full StoryEllenbarrie Industrial Gases Limited's IPO Proceeds Fully Compliant Per CRISIL Monitoring Report for Q2 2026
Ellenbarrie Industrial Gases Limited has submitted the Monitoring Agency Report issued by CRISIL Ratings Limited for the quarter ended September 30, 2026, confirming that the company utilized IPO proceeds in line with the objects stated in its offer document.
Read Full Story